Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: GATEWAY BIOTECHNOLOGY, INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-18 to 2026-01-17
Current total value of award: $1299999.26
Description: MEDICAL RESEARCH AND DEVELOPMENT CONTRACT DHA SBIR PH II, PROPOSAL NO. H2S-0048, TITLED: "GW-TT2, A NEW DRUG PRODUCT FOR TINNITUS"